View Post

Pancreatic cancer patient in partial remission after experimental drug treatment

In Clinical Trials by Barbara Jacoby

By: Ronda Wendler From: Allison Lippman was 30 years old when she was diagnosed with stage 4 pancreatic cancer. A new drug that targets her cancer’s genetic mutation has shrunk her tumors in half. Just before she was diagnosed with pancreatic cancer, Allison Lippman was on top of the world. She’d just celebrated her 30th birthday, been promoted at …